Showing results (381-390 of 403) with videos related to

Sort By:
Pageof 41
Nature Communications|July 4, 2018
Uhrf1 regulates active transcriptional marks at bivalent domains in pluripotent stem cells through Setd1aKun-Yong Kim, Yoshiaki Tanaka, Juan Su, et al.
The Lancet. Global Health|January 27, 2019
Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling studyKrishna P Reddy, Ankur Gupta-Wright, Katherine L Fielding, et al.
The Pediatric Infectious Disease Journal|March 19, 2019
What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management StrategiesGabriela Patten, Michael Schomaker, Mary-Ann Davies, et al.
Epidemiology (Cambridge, Mass.)|October 20, 2015
Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling AnalysisMichael Schomaker, Mary-Ann Davies, Karen Malateste, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2013
Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomesJoseph N Jarvis, Tihana Bicanic, Angela Loyse, et al.
The New England Journal of Medicine|November 1, 2013
Cost-effectiveness of HIV treatment as prevention in serodiscordant couplesRochelle P Walensky, Eric L Ross, Nagalingeswaran Kumarasamy, et al.
The Journal of Infection|May 19, 2022
Diagnostic accuracy of WHO screening criteria to guide lateral-flow lipoarabinomannan testing among HIV-positive inpatients: A systematic review and individual participant data meta-analysisAshar Dhana, Yohhei Hamada, Andre P Kengne, et al.
The Journal of Infectious Diseases|June 21, 2019
Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment TrialChristina Ekenberg, Man-Hung Tang, Adrian G Zucco, et al.
The Lancet. Respiratory Medicine|October 25, 2016
Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trialKen M Kunisaki, Dennis E Niewoehner, Gary Collins, et al.
Plos Medicine|September 7, 2021
Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort studyAndrew F Auld, Andrew D Kerkhoff, Yasmeen Hanifa, et al.
Pageof 41